Introduction
Prior to the development of the nationwide gas pipeline system, gas products for illumination, heating and cooking were produced locally by the distillation of coal. Manufactured gas plant residue, known as coal tar, was a by-product of the gasification process. Coal tar has commercial value in roofing and road surfacing materials, and in certain pharmaceutical products (1) ; nonetheless, the coal tar that was not marketed was often disposed at or near the gasification plants. There are~1500 coal tar waste sites in the US, some near heavily populated areas. Exposure to coal tar is of concern, as it has been classified as a human carcinogen by the International Agency for Research on Cancer (1) .
Over 400 compounds have been identified in coal tar, including polycyclic aromatic hydrocarbons (PAHs*) and aromatic amines, and it is estimated that up to 10 000 compounds may be present (1) . Benzo [a] pyrene, a PAH and suspected *Abbreviations: PAHs, polycyclic aromatic hydrocarbons; HPLC, high performance liquid chromatography.
human carcinogen, has been found in concentrations of up to 6400 mg per kg of coal tar (2), while 2-naphthylamine, an aromatic amine and recognized human urinary bladder carcinogen, has been detected at a concentration of 30 mg per kg (1) .
Coal tars are carcinogenic in experimental animals. In a recent study, for example, Rodriguez et al. (3) reported an increase in liver tumors in B6C3F1 mice when administered a single i.p. injection of coal tar at 15 days of age. Weyand et al. (4) observed an increase in the incidence and multiplicity of lung tumors in A/J mice fed a gel diet containing coal tar. Similarly, Robinson et al. (5) found lung and forestomach tumors in A/J mice treated by gavage with a coal tar paint particulate, and skin tumors have been observed in mice following topical application (1) .
Benzo [a] pyrene has also been shown to be carcinogenic in animals (6) . Increased incidences of forestomach and lung tumors in mice administered benzo[a]pyrene in the feed or by i.p. injection were shown by Weyand et al. (4) , while Rigdon and Neal observed the induction of forestomach and lung tumors, and leukemia in mice fed benzo[a]pyrene (7) (8) (9) (10) (11) . Wislocki et al. (12) and Rodriguez et al. (3) found an increased incidence of liver tumors in mice treated neonatally with i.p. injections of benzo[a]pyrene. As with coal tar, topical application of benzo [a] pyrene has been shown to induce skin tumors in mice (6) .
While coal tars are tumorigenic, the risk associated with exposure to these mixtures has not been established. Complex mixtures, such as coal tar, present a greater challenge for determining risk than does a single carcinogen. It is not feasible to assay each component of a mixture and relate cancer risk from each compound to a tumorigenic outcome. Furthermore, estimating risk based on the individual components in a mixture can be inaccurate because the carcinogenicity of specific components is not necessarily additive (13) . The estimation of the risk associated with coal tar is complicated further by the fact that the nature of the coal tar may vary depending upon the specific feedstock and method of gas production.
In the current study, the tumorigenicity of two coal tar mixtures was compared to that of benzo[a]pyrene in female B6C3F1 mice after 2 years of feeding. Coal tar Mixture 1 was a composite of coal tar from seven manufactured gas plant waste sites, while coal tar Mixture 2 was composed of coal tar with a higher benzo[a]pyrene content. Comparison of tumorigenicity data of Mixture 1 and Mixture 2 allowed determination of how the tumorigenic potential of coal tar mixtures varied as a function of the content of a known carcinogen (benzo[a]pyrene). Comparison of the tumorigenicity data obtained from benzo [a] pyrene to the results obtained with the two mixtures allowed a determination as to whether or not the tumorigenic potential of the coal tar mixtures could be predicted from the concentration of a single tumorigenic component. 
Materials and methods

Chemicals
Coal tar (CAS registry #8007-45-2) Mixture 1 was a composite from seven manufactured gas plant waste sites. Coal tar Mixture 2 was a composite from two of the seven waste sites plus a third site having a very high benzo[a]pyrene content. The PAH composition of the coal tar mixtures was assessed by gas chromatography/mass spectrometry (Table I) 31 meal that had been treated with acetone in a manner identical to the benzo[a]pyrene diets. The diets were fed for 2 years, with the food being removed the evening before death. Necropsy and histopathology All mice, including those that died during the experiment, were examined grossly at necropsy. A histopathological examination was made on the liver, lungs, small intestine, stomach, tongue and esophagus from all mice. The tissues were fixed in 10% neutral buffered formalin, processed, embedded, sectioned, and stained with hematoxylin and eosin for microscopic examination. In addition, a full histopathological examination was conducted on all animals in the following groups: 0.1, 0.3, 0.6 and 1.0% coal tar Mixture 1; 0.03, 0.1 and 0.3% coal tar Mixture 2; 5, 25 and 100 ppm benzo[a]pyrene; and both control groups. All gross lesions found in mice in the other dose groups were also examined histopathologically.
Statistics
Food consumption and body wts in the experimental groups were compared to the appropriate control group. Cages were used as the experimental unit and the response analysed was the average daily food consumption per animal per day or average body wt per cage. A mixed model approach for repeated measures was conducted using a SAS MIXED procedure (SAS Institute, Cary, NC). Dunnett's test was applied to compare the treatment groups means to the respective control group mean at each measurement time.
Organ weights of the experimental animals were compared to the organ weights of the appropriate control group by one-way analysis of variance. Dunnett's test was applied to compare the treatment groups means to the control group mean. In instances where the weights were not normally distributed, a Kruskal-Wallis one-way analysis on ranks was performed and Dunn's method was used for comparing the experimental groups to the appropriate control group.
The mortality from all causes as a function of dose was calculated from a Kaplan-Meier survival curve (15) . Pairwise comparisons were made by using a two-sided logrank test (16). Holm's procedure (17) was applied to correct for multiple comparisons to the same control.
Estimates of tumor incidence, adjusted for competing causes of death and as a function of age, and dose-response trends for tumorigenicity were determined as described in Kodell et al. (18) . A modified Bonferonni procedure (19) was used to correct for multiple comparisons to the same control.
Results
Food consumption, body weights and organ weights
Food consumption was monitored every week for the first 12 weeks on dose and every 4 weeks thereafter. Mice fed 1.0% coal tar Mixture 1 ate significantly less feed (~30% less) than the control mice. Similarly, a significant decrease in food consumption was observed for mice fed 0.6% coal tar Mixture 1 (~25% less) and 0.3% coal tar Mixture 2 (~20% less). Intermittent decreases in food consumption were observed in the other groups fed coal tar Mixtures 1 and 2, with the effect occurring more frequently as the dose was increased. The food consumption of mice fed only benzo[a]pyrene differed only sporadically from that of the control group.
The mean body wts for each of the dose groups are shown in Figure 1 . Mice fed 0.6% and 1.0% coal tar Mixture 1 weighed significantly less than the control group after two weeks of treatment ( Figure 1A) . The body wts of the other groups of mice fed coal tar Mixture 1 differed only sporadically from the control group throughout the entire experiment ( Figure 1A ). Significant decreases in body wt were also observed in mice fed 0.3% coal tar Mixture 2 and 100 ppm benzo[a]pyrene ( Figure 1B and C) .
Liver, kidney and lung weights were determined in mice surviving to the end of the experiment. The livers of mice fed 0.3% coal tar Mixture 1 or 0.3% coal tar Mixture 2 weighed 40% more than the control group, a difference that was significant. None of the other treatment groups showed significant differences in liver weights. Mice fed 0.1% coal tar Mixture 1 had decreased kidney weights compared to the controls. This trend was not evident at higher doses. Likewise, mice fed 0.03% coal tar Mixture 1 had a significant decrease in lung weight. None of the other groups showed significant differences in lung weights.
Morbidity and mortality
None of the mice fed 1.0% coal tar Mixture 1 survived the treatment period (Figure 2A ). The early mortality rate for the mice fed 0.6% coal tar Mixture 1 was also 100%. Only 10 mice (21%) in the 0.3% coal tar Mixture 1 group survived to the end of the 2-year treatment, a difference that was significant (P ϭ 0.00006) from the control group. The survival for the mice in the 0.0, 0.01, 0.03 and 0.1% coal tar Mixture 1 dose groups was 65, 71, 69 and 63%, respectively.
In mice fed coal tar Mixture 2, there was significantly (P ϭ 0.00003) lower survival in the 0.3% dose group (15%) as compared to the control group (65%; Figure 2B ). The survival in the remaining two dose groups was similar to the control group.
All of the mice fed 100 ppm benzo[a]pyrene were removed from study due to morbidity or death ( Figure 2C ). A significant (P ϭ 0.0009) number of mice in the 25 ppm benzo[a]pyrene dose group also died early. The percentage survival of mice fed 5 ppm benzo[a]pyrene (56%) was similar to the control group.
Tumorigenicity Coal tar Mixtures 1 and 2
Liver neoplasms (hepatocellular adenomas, carcinomas, or both) were not detected in the control group, but occurred in all dose groups fed coal tar Mixtures 1 and 2 (Table III) . A significant dose-related trend was observed and in the 0.3% dose groups, the incidence was significantly greater than the control group. Multiple liver neoplasms were present in one mouse from the 0.03% coal tar Mixture 1 group, in four mice from the 0.3% coal tar Mixture 1 group and in five mice from the 0.03% coal tar Mixture 2 group. Liver carcinomas were present in one mouse from the 0.01% group, one mouse from the 0.1% group and two mice from the 0.3% dose group of coal tar Mixture 1; and in two mice from the 0.03% group and three mice from the 0.3% group of coal tar Mixture 2.
Alveolar/bronchiolar adenomas, carcinomas, or both were present in the control group and in all groups of mice fed coal tar Mixtures 1 and 2 (Table III) . With coal tar Mixture 1, the incidence in the 0.3, 0.6 and 1.0% dose groups was significantly increased compared to the control group and a significant dose-related trend was observed. A significant dose-related trend was also found with coal tar Mixture 2 and the frequency was significantly increased in the 0.1 and 0.3% dose groups. Multiple lung neoplasms occurred in 21 mice from 0.3% group, 11 mice from the 0.6% group and 13 mice from the 1.0% group of coal tar Mixture 1; and in eight mice from 0.3% coal tar Mixture 2. The predominant lung lesions were adenomas, with only 15 carcinomas being detected (one each in the 0.0, 0.03, 0.1 and 1.0% groups, two in the 0.6% group and four in the 0.3% group of coal tar Mixture 1; two in the 0.1% group and three in the 0.3% group of coal tar Mixture 2), an incidence that was not significant in any dose group.
Papillomas and/or carcinomas of the forestomach squamous epithelium occurred in all groups of mice treated with coal tar Mixtures 1 and 2 (Table III) . Forestomach neoplasms were not detected in the control group. The induction of the neoplasms showed a highly significant dose-related effect and the increase was significant in the 0.3 and 0.6% groups. Squamous cell carcinomas occurred in two mice from the 0.1% group, seven mice from the 0.3% group, ten mice from the 0.6% group, and four mice from the 1.0% group of coal tar Mixture 1; and 120 in one mouse from the 0.1% group and six mice from the 0.3% group of coal tar Mixture 2. The incidence of carcinomas was significantly elevated in the 0.3 and 0.6% dose groups, and a highly significant (P Ͻ 0.00001) dose effect occurred. Multiple carcinomas were detected in two mice from the 0.6% group and in a single mouse from the 1.0% group of coal tar Mixture 1. A statistically significant incidence of adenocarcinomas of the small intestines (jejunum) was found in mice fed 0.6 and 1.0% coal tar Mixture 1 (Table III) . This neoplasm was not detected in the control group or any of the other groups fed coal tar Mixture 1. Multiple adenocarcinomas were present in two of the mice in the 0.6% group and 12 of the mice in the 1.0% group. One mouse fed 0.3% coal tar Mixture 2 developed an adenocarcinoma of the small intestine (Table III) . The coal tar mixtures also induced dose-related increases in hemangiosarcomas, histiocytic sarcomas and sarcomas (Table III) .
Benzo[a]pyrene
Papillomas and/or carcinomas of the forestomach squamous epithelium were present in all groups of mice treated with benzo[a]pyrene and in the solvent control group (Table IV) . The induction of the neoplasms showed a highly significant dose-related effect, with the incidence being significantly increased in the 25 and 100 ppm groups. Multiple neoplasms occurred in eight of the mice fed 25 ppm benzo[a]pyrene and 21 of the mice fed 100 ppm benzo[a]pyrene. Squamous cell carcinomas occurred in one mouse from the 5 ppm group, 30 mice from the 25 ppm group and 45 mice from the 100 ppm group. The induction of the carcinomas showed a highly significant dose-related effect (P Ͻ 0.00001), and the incidence was significantly increased in the 25 and 100 ppm groups.
Squamous cell papillomas or carcinomas of the epithelial lining of the esophagus were present in mice fed 25 and 100 ppm benzo[a]pyrene (Table IV) . The incidence in the mice fed 100 ppm benzo[a]pyrene was significantly increased compared to the solvent-control group and a significant dose effect occurred. Carcinomas occurred in a single mouse from the 25 ppm group and in 11 mice from the 100 ppm group, the latter incidence being a significant increase (P Ͻ 0.003). Multiple neoplasms occurred in six mice from the 100 ppm group.
Papillomas and/or squamous cell carcinomas of the epithelial layer on the dorsal surface of the base of the tongue were found in the mice fed 25 and 100 ppm benzo[a]pyrene (Table IV) . The incidence in the mice fed 100 ppm benzo[a]pyrene was significantly increased compared to the solventcontrol group and a significant dose effect occurred. Carcinomas occurred in seven mice from the 100 ppm group, an incidence that was significant (P Ͻ 0.04). Multiple neoplasms occurred in three mice from the 100 ppm group.
Squamous cell papillomas and/or carcinomas of the larynx occurred in mice fed 25 and 100 ppm benzo[a]pyrene (Table IV) . One mouse from the 100 ppm group had multiple neoplasms and two mice from the same group had carcinomas. A single mouse from the 100 ppm group had a papilloma of the pharynx. The incidence of liver and lung tumors, hemangiosarcomas, histiocytic sarcomas, and sarcomas was not increased in the mice fed benzo[a]pyrene (Table IV) .
Discussion
Compared to benzo[a]pyrene, the coal tar mixtures induced a wide variety of tumors. Adenocarcinomas of the small intestine, an uncommon tumor in mice, were not found in mice fed benzo[a]pyrene but were responsible for the early mortality observed in mice fed 0.6 and 1.0% coal tar Mixture 1. The fungicide captafol has been shown to induce both small intestine and forestomach tumors in mice, in particular B6C3F1 mice (20) , the strain used in this bioassay. Studies with the related fungicide captan (1,2,3,6-tetrahydro-N-trichloromethylthiophthalimide) have indicated that the intestine tumors result from an increase in cell proliferation related to tyrosine kinase activity and tyrosine-specific phosphorylation of mucosal membrane proteins (21) . Such a mechanism may apply to coal tarinduced small intestine tumors. In ancillary studies, we have observed nearly a 50% increase in the number of S-phase cells in the small intestines of mice fed 0.6 and 1.0% coal tar Mixture 1 for 4 weeks (22) . A similar increase was not detected in mice fed 0.01 or 0.3% coal tar Mixture 1 for the same period. In further studies, DNA adduct levels in the small intestines were analysed by a 32 P-post-labeling assay in mice fed 0.01, 0.3, 0.6 and 1.0% coal tar Mixture 1 for 4 weeks (23). The adduct levels increased with dose until the 0.6% dose and then decreased, such that the adduct levels in the mice fed 1.0% coal tar Mixture 1 were nearly identical to those found with the 0.3% dose. Since small intestine tumors were not observed with 0.3% coal tar Mixture 1, these results suggest that the coal tar-related DNA adducts were not by 121 themselves sufficient to cause tumors in the small intestine, but that coal tar-induced cell proliferation was also required. This marked non-linearity in tumor response has been observed with other carcinogens, and has been attributed to chemicallyinduced cell proliferation that occurs at higher doses (24) . Papillomas and/or carcinomas of the forestomach squamous epithelium were observed in mice fed benzo With the coal tar mixtures, the incidence of forestomach tumor increased markedly between the 0.1 and 0.3% doses. For coal tar Mixture 1, this corresponded to an intake of~8.0 and 23.7 µg benzo[a]pyrene per day, respectively; the corresponding values for coal tar Mixture 2 were 13.2 and 36.3 µg benzo[a]pyrene per day. At coal tar doses above 0.3% there was not a Mice treated with benzo[a]pyrene showed a significant increase in esophageal and tongue tumors at the 100 ppm dose. These tumors were not observed in the mice fed coal tar, presumably because at the highest dose of 1.0%, the daily intake of benzo[a]pyrene was 63 µg, which is considerably less than the 430 µg benzo[a]pyrene per day received by the mice in the 100 ppm benzo[a]pyrene group. This interpretation is consistent with the fact the mice fed 25 ppm benzo[a]pyrene (104 µg per day) did not show an increase in either esophageal or tongue tumors.
An increased incidence of alveolar/bronchiolar adenomas and carcinomas was found in mice treated with the coal tar mixtures, with the increase becoming significant at the 0.1% dose of coal tar Mixture 2 and the 0.3% dose of coal tar Mixture 1. Since a similar increase in lung tumors was not observed in mice fed benzo[a]pyrene, this suggested that the coal tar-induced lung tumors were not due to benzo[a]pyrene but resulted from other chemicals contained within the mixtures. 32 P-Post-labeling analyses have been conducted on lung DNA from mice fed the coal tar mixtures for 1 month in a manner similar to the bioassay (22) . These assays showed a dose-dependent increase in total DNA adducts that paralleled the increase in tumorigenicity. In other experiments, transition and transversion mutations involving deoxyguanosine have been demonstrated at codons 12 and 13 of the K-ras oncogene in nearly 50% of the lung tumors (22) . Taken together, these results suggest that although benzo[a]pyrene in the coal tar did not appear to be responsible for the induction of the lung tumors, the tumors resulted from genotoxic agents within the mixture that reacted primarily with deoxyguanosine.
In In summary, the coal tar mixtures induced dose-related increases in a wide variety of tumors including hepatocellular adenomas and carcinomas, alveolar/bronchiolar adenomas and carcinomas, forestomach squamous epithelial papillomas and carcinomas, and small intestine adenocarcinomas. A comparison of the results obtained from feeding mice benzo[a]pyrene indicated that the benzo[a]pyrene in the coal tar diets could be responsible for the forestomach tumors. In contrast, the lung and liver tumors appeared to be due to other genotoxic components contained within the coal tar mixture, while the small intestine tumors resulted from chemically-induced cell proliferation that occurred at high doses of coal tar.
